BindingDB logo
myBDB logout

2 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
25101911 95 Structure-activity relationship of 3,5-diaryl-2-aminopyridine ALK2 inhibitors reveals unaltered binding affinity for fibrodysplasia ossificans progressiva causing mutants.EBI Massachusetts Institute of Technology
23547776 25 Development of an ALK2-Biased BMP Type I Receptor Kinase Inhibitor.BDB Massachusetts Institute of Technology